Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Ontrak ( (OTRK) ) has shared an update.
On July 2, 2025, Ontrak, Inc. was informed by a prospective partner that it would not pursue a partnership, affecting up to 9,000 lives for Wholehealth+ and 20,000 for Engage. Despite this setback, Ontrak continues to engage with four prospects in advanced sales stages, representing up to 13,000 lives for Wholehealth+ and 20,000 for Engage, and has 20 additional active prospects representing approximately 15 million plan lives.
The most recent analyst rating on (OTRK) stock is a Buy with a $60.00 price target. To see the full list of analyst forecasts on Ontrak stock, see the OTRK Stock Forecast page.
Spark’s Take on OTRK Stock
According to Spark, TipRanks’ AI Analyst, OTRK is a Underperform.
Ontrak’s overall stock score is low due to significant financial challenges, negative technical indicators, and unattractive valuation metrics. The company’s financial instability and operational inefficiencies are the primary factors weighing down its performance.
To see Spark’s full report on OTRK stock, click here.
More about Ontrak
Ontrak, Inc. operates in the healthcare industry, focusing on providing programs as a Medicaid provider. The company offers solutions such as Wholehealth+ and Engage, aiming to improve clinical and financial outcomes for health plan customers.
Average Trading Volume: 324,168
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.54M
For detailed information about OTRK stock, go to TipRanks’ Stock Analysis page.